Omnicell Floating $500 Million Convertible Notes Issue

Omnicell (NASDAQ:OMCL) is hoping to reap at least $500 million from an upcoming round of capital raising. The company, which specializes in automation solutions for the pharmaceutical industry, is floating an issue of unsecured, convertible senior notes at that aggregate principal amount. They will be sold in a private placement to qualified institutional buyers. The timing of the issue has not been set.

The notes mature in 2025, and will pay interest semi-annually; the rate will be determined when the issue is priced. They will be convertible either to shares of Omnicell common stock, cash, or a combination of the two. As with the interest, the conversion rates have not yet been set.

Stethoscope atop 100 dollar bills and pennies.

Image source: Getty Images.

The company added that it plans to offer the initial purchasers of the notes an option to buy up to $75 million more of the notes in aggregate principal amount. This option will

Read More

Read More